Alison Parisian

Alison Parisian, PhD, is a Senior Scientist at Exelixis since September 2023, focusing on target identification for small-molecule drug discovery and evaluating preclinical data for business development assets. Prior experience includes serving as Project Lead at Olema Oncology, where Alison directed a drug discovery program and authored a preclinical manuscript, alongside roles as Scientist II and I, conducting in vitro experiments and generating patent-enabling data. Alison's academic foundation includes a PhD in Biomedical Sciences from UC San Diego and a BS in Biology from Caltech, with research experience in pediatric brain tumors and various laboratory techniques, along with earlier research roles at OLEMA Pharmaceuticals, UC Berkeley, and Caltech.